Horn Howard — SEC insider filings

SEC reporting owner CIK 1786335. 22 insider filings on record with FilingPulse; latest filed 2026-10-19.

Transaction summary — filings shown

Covers all 22 filings on record, filed 2021-02-18 to 2026-10-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Ultragenyx Pharmaceutical Inc. (RARE)Chief Financial Officer17—15 legs · 67,007 sh · $1,905,8869
Vir Biotechnology, Inc. (VIR)CFO5—3 legs · 7,065 sh · $196,0964

Insider filings — Horn Howard

FiledFormIssuerReported transactionsSource
2026-10-194Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 7,066 @ $15.27EDGAR
2026-08-044Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 4,696 @ $24.92EDGAR
2026-07-064Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 4,698 @ $33.13EDGAR
2026-06-014Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 4,653 @ $23.77EDGAR
2026-05-044Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 4,683 @ $24.90EDGAR
2026-04-204Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 34,674 @ $0 · Grant/award (A): 59,952 (derivative) @ $0EDGAR
2026-04-024Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 4,683 @ $20.97EDGAR
2026-03-034Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 6,143 @ $0 · Sale (S): 5,290 @ $22.80 · Sale (S): 3,119 @ $22.54 · Sale (S): 1,635 @ $22.40EDGAR
2026-02-034Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 3,061 @ $23.56EDGAR
2026-01-054Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 3,150 @ $22.84EDGAR
2025-12-114Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 3,081 @ $36.38EDGAR
2025-10-144Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 7,942 @ $31.51EDGAR
2025-03-104Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 1,785 @ $40.40EDGAR
2025-03-044Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 15,653 @ $0 · Grant/award (A): 28,160 (derivative) @ $0EDGAR
2024-10-114Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 7,465 @ $52.76EDGAR
2024-03-054Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 19,400 @ $0 · Grant/award (A): 34,200 (derivative) @ $0EDGAR
2023-10-104Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 80,366 @ $0 · Grant/award (A): 140,469 (derivative) @ $0EDGAR
2023-02-244Vir Biotechnology, Inc. (VIR)Sale (S): 2,248 @ $25.97EDGAR
2023-02-214Vir Biotechnology, Inc. (VIR)Sale (S): 2,424 @ $25.29EDGAR
2022-02-244Vir Biotechnology, Inc. (VIR)Grant/award (A): 35,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2022-02-224Vir Biotechnology, Inc. (VIR)Sale (S): 2,393 @ $31.93EDGAR
2021-02-184Vir Biotechnology, Inc. (VIR)Grant/award (A): 25,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1786335 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs